OSF
open access
A Unified Architecture for 7-Hydroxymitragynine Recovery: Integrating Neuroscience, Cognitive Behavioral Therapy, and the Twelve-Step Tradition
Background: The proliferation of high-potency 7-hydroxymitragynine (7-OH) isolates in 2026 has introduced a novel clinical presentation that traditional recovery models are ill-equipped to manage. Main body: This perspective piece proposes a Unified Architecture for recovery, a heuristic framework
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Psychedelic-assisted Group Program for First Responders#1150201
- Safety and Effectiveness of NXY-059 for the Treatment of Patients Who Have Suffered From a Stroke#1046679
- Fall 2025 NURS217 Sect. 1 Pathophysiology/Pharmacology I#387372
- Phase 1 SAD/MAD Study of CVN766 in Healthy Volunteers#908480
- Donepezil Trial for Motor Recovery in Acute Stroke#994370
Record · ID 1391700
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive